Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Vilgrain

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biotechnology Journal|November 21, 2018
A Biomimetic Lipid Membrane Device Reveals the Interaction of Cancer Biomarkers with Human Serum Lipidic MoietiesAbir Khalil-Mgharbel, Helena Polena, Paul K Dembélé, et al.
International Archives of Allergy and Immunology|August 1, 2016
BIOBRAD Study: The Search for Biomarkers of Bradykinin-Mediated Angio-Oedema AttacksAlban Deroux, Chantal Dumestre-Perard, Abir Khalil-Mgharbel, et al.
Journal of Colloid and Interface Science|January 9, 2026
How lipid composition shapes the nanostructural interaction of tumor biomarker alpha-fetoprotein and bovine serum albumin with model membranesBeatrice Barletti, Melanie König, Nicoló Paracini, et al.
The European Respiratory Journal|March 19, 2021
VE-cadherin cleavage in sleep apnoea: new insights into intermittent hypoxia-related endothelial permeabilityOlfa Harki, Renaud Tamisier, Jean-Louis Pépin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 27, 2014
Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterusAdama Sidibé, Helena Polena, Jeremy Razanajatovo, et al.
Arthritis and Rheumatism|September 10, 2011
Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavageAdama Sidibé, Tiphaine Mannic, Mélanie Arboleas, et al.
British Journal of Cancer|January 6, 2017
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survivalPauline Rochefort, Sylvie Chabaud, Jean-Yves Pierga, et al.
International Journal of Molecular Sciences|July 9, 2022
Inhibition of Vascular Endothelial Cadherin Cleavage Prevents Elastic Fiber Alterations and Atherosclerosis Induced by Intermittent Hypoxia in the Mouse AortaOlfa Harki, Sophie Bouyon, Marine Sallé, et al.
Joint Bone Spine|December 25, 2016
Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumabChristopher Banse, Helena Polena, Barry Stidder, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 27, 2014
VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organsAdama Sidibé, Helena Polena, Karin Pernet-Gallay, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biotechnology Journal|November 21, 2018
A Biomimetic Lipid Membrane Device Reveals the Interaction of Cancer Biomarkers with Human Serum Lipidic MoietiesAbir Khalil-Mgharbel, Helena Polena, Paul K Dembélé, et al.
International Archives of Allergy and Immunology|August 1, 2016
BIOBRAD Study: The Search for Biomarkers of Bradykinin-Mediated Angio-Oedema AttacksAlban Deroux, Chantal Dumestre-Perard, Abir Khalil-Mgharbel, et al.
Journal of Colloid and Interface Science|January 9, 2026
How lipid composition shapes the nanostructural interaction of tumor biomarker alpha-fetoprotein and bovine serum albumin with model membranesBeatrice Barletti, Melanie König, Nicoló Paracini, et al.
The European Respiratory Journal|March 19, 2021
VE-cadherin cleavage in sleep apnoea: new insights into intermittent hypoxia-related endothelial permeabilityOlfa Harki, Renaud Tamisier, Jean-Louis Pépin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 27, 2014
Dynamic phosphorylation of VE-cadherin Y685 throughout mouse estrous cycle in ovary and uterusAdama Sidibé, Helena Polena, Jeremy Razanajatovo, et al.
Arthritis and Rheumatism|September 10, 2011
Soluble VE-cadherin in rheumatoid arthritis patients correlates with disease activity: evidence for tumor necrosis factor α-induced VE-cadherin cleavageAdama Sidibé, Tiphaine Mannic, Mélanie Arboleas, et al.
British Journal of Cancer|January 6, 2017
Soluble VE-cadherin in metastatic breast cancer: an independent prognostic factor for both progression-free survival and overall survivalPauline Rochefort, Sylvie Chabaud, Jean-Yves Pierga, et al.
International Journal of Molecular Sciences|July 9, 2022
Inhibition of Vascular Endothelial Cadherin Cleavage Prevents Elastic Fiber Alterations and Atherosclerosis Induced by Intermittent Hypoxia in the Mouse AortaOlfa Harki, Sophie Bouyon, Marine Sallé, et al.
Joint Bone Spine|December 25, 2016
Soluble vascular endothelial (VE) cadherin and autoantibodies to VE-cadherin in rheumatoid arthritis patients treated with etanercept or adalimumabChristopher Banse, Helena Polena, Barry Stidder, et al.
American Journal of Physiology. Heart and Circulatory Physiology|May 27, 2014
VE-cadherin Y685F knock-in mouse is sensitive to vascular permeability in recurrent angiogenic organsAdama Sidibé, Helena Polena, Karin Pernet-Gallay, et al.
Pageof 4